Rigel to Participate in Upcoming September Investor Conferences

Rhea-AI Summary

Rigel Pharmaceuticals (NASDAQ:RIGL), a biotechnology company focused on hematologic disorders and cancer, has announced its participation in four major investor conferences this September 2025.

The company's leadership, including CEO Raul Rodriguez and CFO Dean Schorno, will attend the Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, Wells Fargo Healthcare Conference, and H.C. Wainwright Global Investment Conference. Company presentations are scheduled at Cantor (September 3, 8:35 a.m. ET) and H.C. Wainwright (September 9, 1:30 p.m. ET), with webcasts available through Rigel's investor relations website.

News Market Reaction

+2.16%

9 alerts

+2.16% News Effect

+$15M Valuation Impact

$714M Market Cap

0.4x Rel. Volume

On the day this news was published, RIGL gained 2.16%, reflecting a moderate positive market reaction. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $15M to the company's valuation, bringing the market cap to $714M at that time.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., Aug. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and chief executive officer, and Dean Schorno, the company's chief financial officer, will participate in the following investor conferences in September:

• Citi's 2025 Biopharma Back to School Conference in Boston, MA
  Rigel will participate in one-on-one meetings on Tuesday, September 2.
  
  
• Cantor Global Healthcare Conference 2025 in New York, NY
  Rigel will participate in one-on-one meetings and present a company overview on Wednesday, September 3, at 8:35 a.m. ET.
  
  
• 2025 Wells Fargo Healthcare Conference in Boston, MA
  Rigel will participate in one-on-one meetings on Thursday, September 4.
  
  
• H.C. Wainwright 27^th Annual Global Investment Conference in New York, NY
  Rigel will participate in one-on-one meetings and present a company overview on Tuesday, September 9, at 1:30 p.m. ET.

To access the live webcasts or archived recordings of the Cantor and H.C. Wainwright Conference presentations, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors: 
Rigel Pharmaceuticals, Inc. 
650.624.1232 
ir@rigel.com

Media: 
David Rosen 
Argot Partners 
646.461.6387
david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-302538238.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When is Rigel Pharmaceuticals (RIGL) presenting at the Cantor Global Healthcare Conference 2025?

Rigel will present at the Cantor Global Healthcare Conference on Wednesday, September 3, 2025, at 8:35 a.m. ET in New York, NY.

How can investors access Rigel's (RIGL) conference presentations in September 2025?

Investors can access the live webcasts and archived recordings of the Cantor and H.C. Wainwright Conference presentations through the Investor Relations section of Rigel's website at www.rigel.com.

Which investor conferences is Rigel Pharmaceuticals (RIGL) attending in September 2025?

Rigel is attending four conferences: Citi's Biopharma Back to School Conference (Sept 2), Cantor Global Healthcare Conference (Sept 3), Wells Fargo Healthcare Conference (Sept 4), and H.C. Wainwright Global Investment Conference (Sept 9).

Who will represent Rigel Pharmaceuticals (RIGL) at the September 2025 investor conferences?

Raul Rodriguez, President and CEO, and Dean Schorno, CFO, will represent Rigel at the September investor conferences.